Price Data


Syneron Medical Ltd. (NASDAQ: ELOS) is a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint.

The Company’s technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring,  hair removal, wrinkle reduction, improving the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela.  

Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US.  The company markets, services and supports its products in 86 countries.  It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

Additional information can be found at

September 17 Investors Meeting replay is available HERE

Download the Syneron September 17 Investors Meeting Presentation HERE

Download The UltraShape FDA Clearance Conference Call Presentation HERE



Syneron Investor Presentation November 2014
Syneron Investor Presentation November 2014 (2.8 MB)

Syneron Events
Wednesday, February 18, 2015
8:30am EST

Syneron management will host a conference call and a live webcast. A question & answer session will follow management's discussion of events in the fourth quarter 2014. Investors and analysts may...

Thursday, February 12, 2015
11:35am EST

Sarit Soccary Ben Yochanan, Vice President of Business Development and Strategy, and Brian Hayes, Vice President of Body Shaping Group, are scheduled to participate in the 2015 Leerink Global...

See calendar